FDA UNTITLED_LETTER - Mytilini Enterprises LLC dba Bedford Pharmacy Inc. - October 04, 2019

FDA UNTITLED_LETTER for Mytilini Enterprises LLC dba Bedford Pharmacy Inc. on October 04, 2019. Product: N/A. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA UNTITLED_LETTER for Mytilini Enterprises LLC dba Bedford Pharmacy Inc. on October 04, 2019. Product: N/A. Access full analysis and detailed observations.

Violation Codes

FD&C Act 501(a)(2)(B)

21 U.S.C. 331(k)

21 CFR 211.67(a)

21 U.S.C. 355

21 CFR 211.165(a)

21 U.S.C. 352(f)(1)

21 U.S.C. 351(a)(2)(B)

FD&C Act 505

21 CFR 211.160(b)(4)

FD&C Act 502(f)(1)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Mytilini Enterprises LLC dba Bedford Pharmacy Inc.

Inspection Date

October 4, 2019

Product Type

People

Craig W. Swanson (Deputy District Director)

ID: e8a62053-74a4-4296-be63-dc6c836e586b

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox